| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation. | Biol Blood Marrow Transplant | 2011 | 1.96 |
| 2 | Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose. | Blood | 2004 | 1.02 |
| 3 | CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies. | Exp Hematol | 2005 | 0.91 |
| 4 | Relationships between repeated sprint testing, speed, and endurance. | J Strength Cond Res | 2008 | 0.89 |
| 5 | Medical planning and response for a nuclear detonation: a practical guide. | Biosecur Bioterror | 2012 | 0.87 |